Buy Tegsedi 284 mg/1.5 mL

Buy Tegsedi 284 mg/1.5 mL

Buy Tegsedi 284 mg/1.5 mL Tegsedi, with a dosage strength of 284 mg/1.5 mL, is a medication used to treat a rare genetic disease called hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adults. This disease occurs when a protein called transthyretin is made in an abnormal form, leading to the buildup of amyloids in various organs and tissues in the body, such as the heart and nerves. This causes symptoms like heart failure, nerve pain, and trouble with movement. Tegsedi works by reducing the amount of abnormal transthyretin protein produced in the liver, thus slowing down the accumulation of amyloids and potentially improving the patient’s quality of life. It is administered through injections under the skin, typically by the patients themselves or their caregivers, once a week.